Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 10/20 | 0.53 |
| ▸ | CSF1R | P07333 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.46 |
| ▸ | MET | P08581 | 2/20 | 0.43 |
| ▸ | AXL | P30530 | 1/20 | 0.42 |
| ▸ | MERTK | Q12866 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL488677 | 1.00 | ATR (0.53) | ATRCSF1RKCNH2METAXL | |
| SCHEMBL488768 | 0.93 | ATR (0.54) | ATRCSF1RMETAXLMERTK | |
| SCHEMBL30454051 | 0.93 | ATR (0.54) | ATRCSF1RMETAXLMERTK | |
| SCHEMBL30454874 | 0.87 | KCNH2 (0.56) | ATRKCNH2 | |
| SCHEMBL488626 | 0.87 | KCNH2 (0.56) | ATRKCNH2 | |
| SCHEMBL30454737 | 0.85 | MET (0.57) | ATRMETAXLMERTKKDM4E | |
| SCHEMBL488031 | 0.85 | MET (0.57) | ATRMETAXLMERTKKDM4E | |
| SCHEMBL488885 | 0.83 | CSF1R (0.70) | ATRCSF1RMET | |
| SCHEMBL488886 | 0.83 | CSF1R (0.70) | ATRCSF1RMET | |
| SCHEMBL30454180 | 0.83 | CSF1R (0.70) | ATRCSF1RMET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113181362-B | Medicament for preventing and/or treating amyotrophic lateral sclerosis | 国立大学法人京都大学 | 2023-06-13 | — | — | CN | disclosed |